Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, May 19, 2013
Technology Networks
 
Register | Sign in
Home Page
  News

‘Tis the Season to Be Sniffly - Seasonal Influenza Boosts Vaccines Market

Published: Monday, October 22, 2012
Last Updated: Monday, October 22, 2012
Bookmark and Share
Acute viral respiratory infection influenza, or flu, strikes every winter, and several nations are preparing to tackle this illness through dedicated healthcare schemes, states a new report by healthcare experts GBI Research.

Full access to this article is for registered users only.
Registration is free-of-charge and allows access to all content on our web communities.

Already registered? Then please log in at the top of the page.

Print Page

Scientific News
Results of the ROTAVAC Rotavirus Vaccine Study in India
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.
BBSRC is Major Partner in Europe-wide Synthetic Biology Funding
BBSRC is contributing €3M as a major partner in a new call for research projects in Synthetic Biology.
Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine
Companies announce agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies.
Cocaine Vaccine Passes Key Testing Hurdle
New anti-cocaine vaccine research shows drug can't reach the brain, human clinical trials on the horizon.
Vectura Establishes Strategic Partnership (Kinnovata) for New Respiratory Business in China
Kinnovata to commercialise products in fast growing Asian respiratory markets.
NIH Scientists Create New Tool for Identifying Powerful HIV Antibodies
It is believed that this latest advance could speed HIV vaccine research.
Bird Flu Expert Working on Vaccine that Protects Against Multiple Strains
As the bird flu outbreak in China worsens, a Purdue University expert is working on vaccines that offer broader protection against multiple strains of the virus.
GSK and Save the Children Partner to Help Africa
Currently, nearly 7 million children under five die every year from preventable diseases.
H7N9: A Novel Influenza Virus and it’s Control
Whilst the virus remains as one primarily circulating in birds, breaking this cycle of replication is the only effective response to its control.
Genome Sequencing Provides Unprecedented Insight into Causes of Pneumococcal Disease
Technology will allow better surveillance of bacterial populations, understanding of vaccine effectiveness.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net